Natixis Elanco Animal Health Inc Transaction History

Natixis

  • $17.6 Billion
  • Q3 2024

A detailed history of Natixis transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Natixis holds 1,500 shares of ELAN stock, worth $18,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,500
Holding current value
$18,075
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$11.85 - $15.47 $17,775 - $23,205
1,500 New
1,500 $22,000
Q1 2024

May 13, 2024
SELL
$14.37 - $16.46 $6,308 - $7,225
-439 Reduced 2.19%
19,573 $318,000
Q4 2023

Feb 13, 2024
SELL
$8.6 - $14.94 $6.78 Million - $11.8 Million
-788,163 Reduced 97.52%
20,012 $298,000
Q3 2023

Nov 14, 2023
BUY
$9.81 - $12.62 $5.75 Million - $7.39 Million
585,700 Added 263.27%
808,175 $9.08 Million
Q2 2023

Aug 11, 2023
BUY
$8.08 - $10.37 $936,068 - $1.2 Million
115,850 Added 108.65%
222,475 $2.24 Million
Q1 2023

May 12, 2023
SELL
$8.79 - $14.58 $10.5 Million - $17.4 Million
-1,196,691 Reduced 91.82%
106,625 $1 Million
Q4 2022

Feb 24, 2023
SELL
$11.49 - $13.65 $474,077 - $563,199
-41,260 Reduced 3.07%
1,303,316 $15.9 Million
Q4 2022

Feb 13, 2023
BUY
$11.49 - $13.65 $10.1 Million - $12 Million
876,551 Added 187.29%
1,344,576 $16.4 Million
Q3 2022

Nov 14, 2022
SELL
$12.41 - $32.42 $9.15 Million - $23.9 Million
-737,096 Reduced 61.16%
468,025 $5.81 Million
Q2 2022

Aug 12, 2022
SELL
$19.63 - $26.62 $8.98 Million - $12.2 Million
-457,603 Reduced 27.52%
1,205,121 $23.7 Million
Q1 2022

May 13, 2022
BUY
$24.65 - $29.0 $5.2 Million - $6.11 Million
210,802 Added 14.52%
1,662,724 $43.4 Million
Q4 2021

Feb 14, 2022
BUY
$27.74 - $34.09 $22 Million - $27.1 Million
794,591 Added 120.88%
1,451,922 $41.2 Million
Q3 2021

Nov 12, 2021
BUY
$29.2 - $36.72 $18.7 Million - $23.6 Million
641,793 Added 4130.47%
657,331 $21 Million
Q2 2021

Aug 13, 2021
SELL
$28.76 - $35.98 $24.7 Million - $30.8 Million
-857,102 Reduced 98.22%
15,538 $539,000
Q1 2021

May 14, 2021
BUY
$27.85 - $34.49 $18.6 Million - $23 Million
667,251 Added 324.87%
872,640 $25.7 Million
Q4 2020

Feb 12, 2021
SELL
$27.53 - $33.79 $86.7 Million - $106 Million
-3,148,425 Reduced 93.88%
205,389 $6.3 Million
Q3 2020

Nov 12, 2020
BUY
$21.1 - $29.13 $62.6 Million - $86.5 Million
2,968,719 Added 770.91%
3,353,814 $93.7 Million
Q2 2020

Aug 13, 2020
SELL
$18.94 - $24.93 $27.9 Million - $36.8 Million
-1,474,932 Reduced 79.3%
385,095 $8.26 Million
Q1 2020

May 14, 2020
BUY
$16.68 - $32.25 $25.1 Million - $48.5 Million
1,503,137 Added 421.18%
1,860,027 $41.6 Million
Q4 2019

Feb 14, 2020
SELL
$25.29 - $29.45 $1.41 Million - $1.64 Million
-55,662 Reduced 13.49%
356,890 $10.5 Million
Q2 2019

Aug 13, 2019
BUY
$31.11 - $34.79 $12.8 Million - $14.4 Million
412,552 New
412,552 $13.9 Million

Others Institutions Holding ELAN

# of Institutions
437
Shares Held
473M
Call Options Held
4.62M
Put Options Held
753K
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.71B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email